- Open Access
Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?
Journal of Translational Medicine volume 16, Article number: 122 (2018)
- The original article was published in Journal of Translational Medicine 2018 16:3
Correction to: J Transl Med (2018) 16:3 https://doi.org/10.1186/s12967-017-1378-2
Following publication of the original article , the authors reported that they omitted to state that parts of Fig. 2 were adapted from Van Acker et al.  published by Taylor & Francis Ltd (www.tandfonline.com). The authors apologise for this omission. Figure 2 and its corrected caption are given below.
Zhao Y, Niu C, Cui J. Gamma-delta (γδ) T cells: friend or foe in cancer development? J Transl Med. 2018;16:3. https://doi.org/10.1186/s12967-017-1378-2.
Van Acker HH, Anguille S, Van Tendeloo VF, Lion E. Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. OncoImmunology. 2015;4(8):e1021538.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhao, Y., Niu, C. & Cui, J. Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?. J Transl Med 16, 122 (2018). https://doi.org/10.1186/s12967-018-1491-x